Dr. Shah on the Importance of CAR T-Cell Therapy for ALL

Bijal D. Shah, MD, medical oncology, Moffit Cancer Center, discusses the importance of chimeric antigen receptor (CAR) T-cell therapy for patients with acute lymphoblastic leukemia (ALL).

According to Shah, CAR T-cell therapy is the most promising therapy for patients with ALL. There are toxicities but the toxicities are manageable for the majority of patients. The risk of dying from toxicities is less than 5%.